Equillium Earnings Estimates, EPS & Revenue | NASDAQ:EQ

Comments

Equillium Inc Earnings Estimates

EQNASDAQ

Trade with Public

$2.47

0.4019.32%

At close: Mar 13, 5:00 PM EST

$2.53

0.05882.38%

After Hours: 7:58 PM EST

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Equillium Earnings Estimates, EPS & Revenue | NASDAQ:EQ

Equillium (EQ) is scheduled to report Q4 earnings on March 26, 2026. Analysts estimate EPS of $-0.07 and quarterly revenue of N/A.

In the most recent quarter (Q3), Equillium reported EPS of $-0.06, beating estimates of $-0.19 by 0.68%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Equillium has beaten EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Equillium has averaged an EPS surprise of 0.35% and a revenue surprise of 0.00%.

Earnings Date

Mar 26

EPS Estimate

$-0.070

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

$4.39M

Equillium Earnings History

Analyze the earnings history of Equillium using advanced sorting and filters.

Loading calendar...

Equillium (EQ) Earnings Per Share

The chart below shows Equillium's reported EPS compared to analyst estimates over recent quarters.

Equillium (EQ) Revenue

The chart below shows Equillium's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Equillium (NASDAQ:EQ) reporting earnings?

Equillium (EQ) is scheduled to report earnings on May 13, 2026. The last reported earnings were for reported on November 13, 2025 for Q3.

What were the latest earnings per share (EPS) for Equillium (NASDAQ:EQ)?

The Actual EPS was $-0.06, which beat the estimate of $-0.19.

What were Equillium’s (NASDAQ:EQ) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Gain Therapeutics Inc

Inovio Pharmaceuticals Inc

NASDAQ:INO

$1.69

1.81%

Fate Therapeutics Inc

NASDAQ:FATE

$1.23

5.13%

Sangamo Therapeutics Inc

Equillium Earnings Estimates, EPS & Revenue | NASDAQ:EQ

Equillium (EQ) is scheduled to report Q4 earnings on March 26, 2026. Analysts estimate EPS of $-0.07 and quarterly revenue of N/A.

In the most recent quarter (Q3), Equillium reported EPS of $-0.06, beating estimates of $-0.19 by 0.68%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Equillium has beaten EPS estimates in 2 consecutive quarters.

Over the last 4 quarters, Equillium has averaged an EPS surprise of 0.35% and a revenue surprise of 0.00%.

Earnings Date

Mar 26

EPS Estimate

$-0.070

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

$4.39M